Insurance Access and Demand Response: Pricing and Welfare Implications

We show that insurance coverage for prescription drugs can relax liquidity constraints, thereby permitting innovators to extract a large percentage of the value that their products create. As a result, consumers may be worse off with insurance, even in the absence of moral hazard. We show that this problem is exacerbated in a fragmented market and when regulations require the coupling of drug coverage with other medical coverage.